ALZN icon

Alzamend Neuro
ALZN

7 hedge funds and large institutions have $6.36K invested in Alzamend Neuro in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

89% less capital invested

Capital invested by funds: $59.8K → $6.36K (-$53.4K)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.63K
2
+$2.32K
3
+$58
4
Bank of America
Bank of America
North Carolina
+$9

Top Sellers

1
-$37.1K
2
-$14.7K
3
-$4K
4
CSB
City State Bank
Iowa
-$4
5
HIA
Harbor Investment Advisory
Maryland
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$2.63K
TRCT
2
Tower Research Capital (TRC)
New York
$2.32K
BlackRock
3
BlackRock
New York
$1.28K
SS
4
SBI Securities
Japan
$64
Bank of America
5
Bank of America
North Carolina
$55
AWM
6
Activest Wealth Management
Florida
$6
HIA
7
Harbor Investment Advisory
Maryland
$3
Geode Capital Management
8
Geode Capital Management
Massachusetts
–
Truist Financial
9
Truist Financial
North Carolina
–
Barclays
10
Barclays
United Kingdom
–
PA
11
Parallel Advisors
California
–
Morgan Stanley
12
Morgan Stanley
New York
–
CSB
13
City State Bank
Iowa
–